En
Da
Fr
De
Sv
Deal History
About us
The Company
Team
Offices
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
En
Da
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
01 Nov 2024
Equity Research InCoax, Q3 2024: Higher revenues, but also higher costs than expected
Equity Research
InCoax
31 Oct 2024
Equity Research Enrad, Q3 2024: Strong focus on increased production capacity
Equity Research
Enrad
31 Oct 2024
Equity research CDON: A new platform to build marketplace excellence
Equity Research
CDON
25 Oct 2024
Equity research Teneo AI, Q3 2024: Excellent growth driven by increased volumes
Equity Research
Teneo AI
25 Oct 2024
Equity Research Enrad, Q3 2024: Sales in line with expectations, but better than expected gross margin
Equity Research
Enrad
21 Oct 2024
Carlsquare Equity Research: Real Estate Equity Snapshot
Equity Research
ALM Equity
21 Oct 2024
Equity research, Viva Wine Group: We expect solid performance in a slow market in Q3 2024
Equity Research
Viva Wine Group
09 Oct 2024
Carlsquare Weekly Market Letter: Christmas has come early for stock traders this year
Equity Research
04 Oct 2024
Equity research, Zinzino: On track to achieve growth target
Equity Research
Zinzino
02 Oct 2024
Carlsquare weekly market letter: China took the lead – what’s next?
Equity Research
Carlsquare
25 Sep 2024
Carlsquare weekly market letter: Is China finally taking off?
Equity Research
Carlsquare
23 Sep 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
18 Sep 2024
Carlsquare weekly market letter: Another leg down – or time for small caps?
Equity Research
Carlsquare
16 Sep 2024
Carlsquare Equity Research: Swedish consumer sector snapshot
Equity Research
Viva Wine Group
12 Sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research
Biosergen
11 Sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Equity Research
Carlsquare
09 Sep 2024
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
Equity Research
Svenska Aerogel
05 Sep 2024
Equity research Zinzino: Making a late summer splash
Equity Research
Zinzino
04 Sep 2024
Carlsquare weekly market letter: Time for a new bump in the road?
Equity Research
Carlsquare
03 Sep 2024
Equity Research Enrad Q2 2024: Enrad should invest in growing markets
Equity Research
Enrad
1
2
3
…
53